Ulta Lab Tests

CA 125 Test with HAMA Treatment

The CA 125 Test with HAMA Treatment measures levels of cancer antigen 125, a biomarker often elevated in ovarian cancer and some benign conditions. The addition of human anti-mouse antibody (HAMA) treatment minimizes assay interference, improving result accuracy. This test supports evaluation of suspected ovarian malignancy, monitoring of treatment response, and detection of disease recurrence.

Blood
Blood Draw
There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Ca 125, Hama Treated

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The CA 125 Test with HAMA Treatment test contains 1 test with 1 biomarker .

CA 125 is used as an aid in monitoring the response to therapy for patients with epithelian ovarian cancer and in detecting residual ovarian cancer in patients who have undergone therapy. HAMA pre-treatment inhibits possible heterophilic interference.

Customer Reviews